St. Jude Medical (NYSE:STJ) said today that the FDA approved its Infinity deep-brain stimulation device, including its DBS directional leads, to treat Parkinson’s disease and essential tremor. The Infinity system is designed so that Apple (NSDQ:AAPL) mobile devices can be used as wireless controllers, via a Bluetooth connection; St. Jude claims the system as the only upgradable DBS platform for […]
stjudemedical
St. Jude launches EnSite Precision cardiac mapping system in EU
St. Jude Medical (NYSE:STJ) said today it fully launched its EnSite Precision cardiac mapping system and associated tools in Europe, expanding from an earlier limited release. The St. Paul, Minn.-based company touted more than 100 installations of the device across Europe so far, supporting more than 5,000 ablation procedures after a targeted release it expanded in […]
Report: EU regulators to rule on $25B Abbott-St. Jude Medical tie-up by Nov. 9
(Reuters) — Antitrust regulators in the European Union will decide by Nov. 9 whether to clear Abbott‘s (NYSE:ABT) $25-billion bid for St. Jude Medical (NYSE:STJ), aimed at helping it better compete with bigger rivals. Abbott sought the European Commission’s approval for the deal Oct. 3, according to a filing on the EU competition enforcer’s website today. The […]
FDA approves St. Jude Medical’s BurstDR spinal cord stimulation for chronic pain
St. Jude Medical (NYSE:STJ) said today that the FDA granted pre-market approval for its BurstDR spinal cord stimulation technology, which is designed to mimic the body’s natural nerve-firing patterns to optimize SCS treatment for chronic pain. The BurstDR technology is available with new implantations of St. Jude’s Proclaim Elite and Prodigy MRI SCS devices; it will also […]
St. Jude seeks shareholder approval for Abbott merger
Updated to correct St. Jude’s headquarters to St. Paul, Minn. from the inappropriately tagged Memphis, Tenn. St. Jude Medical (NYSE:STJ) is reaching out to shareholders to approve its proposed $25 billion merger with Abbott (NYSE:ABT), according to an SEC filing posted today. The St. Paul, Minn.-based company said the deal will put $46.75 cash in the hands […]
Former St. Jude exec Craig seeks Minn. Congressional seat
Former St. Jude Medical (NYSE:STJ) HR executive Angie Craig is looking to take a seat in Minnesota’s 2nd Congressional district for Democrats this year in a closely watched race. Craig is facing off against libertarian talk-show host Jason Lewis (R) for the seat held by Rep. John Kline (R), who’s retiring after 14 years on Capitol Hill. She spent 10 years at St. […]
Ablative Solutions wins FDA nod for Phase II chemical denervation trial
Ablative Solutions said today that the FDA approved a Phase II trial of its chemical denervation system for hypertension under its investigational new drug application. The trial, called Target-BP I, will evaluate the efficacy of Ablative’s Peregrine infusion ablation system, which uses ethanol to interrupt signals from sympathetic nerves in the renal artery to control […]
Legal eagles: St. Jude Medical faces uphill battle in lawsuit against short-seller
Legal experts say a defamation lawsuit filed by St. Jude Medical (NYSE:STJ) against a short seller faces an uphill battle. Little Canada, Minn.-based St. Jude yesterday sued short-selling firm Muddy Waters Consulting and the hacking shop behind a report of alleged cybersecurity vulnerabilities that’s pushed STJ shares down more than 3% since late last month. The Muddy Waters […]
St. Jude Medical levels lawsuit against short seller
Updated with information from the FDA St. Jude Medical (NYSE:STJ) said today that it sued the short seller and the hacking shop behind a report of alleged cybersecurity vulnerabilities that’s shaved 5% from its share price since August 25. Little Canada, Minn.-based St. Jude said the lawsuit was filed against Muddy Waters Consulting and its founder, well-known […]
Pivotal trial pits St. Jude Medical’s Amplatzer Amulet anti-stroke device against Boston Scientific’s Watchman
St. Jude Medical (NYSE:STJ) said today that it launched a U.S. pivotal trial for its Amplatzer Amulet cardiac implant, which is designed to reduce the risk of stroke in patients with atrial fibrillation. The Amplatzer Amulet device is designed to occlude the left atrial appendage to prevent the formation of blood clots that could lead to […]
Researchers: Short-seller’s claims about St. Jude Medical devices have ‘major flaws’
A short-seller’s report that cardiac rhythm management devices made by St. Jude Medical (NYSE:STJ) are vulnerable to hackers has “major flaws” and doesn’t prove its allegations, according to researchers from the University of Michigan. Muddy Waters, the firm founded by well-known short-seller Carson Block, last week aimed to disrupt the pending, $25 billion acquisition of St. Jude by Abbott (NYSE:ABT); in […]